GENE ONLINE|News &
Opinion
Blog

GLP-1 receptor agonist
Eli LillyGLP-1 receptor agonist
Eli Lilly’s Orforglipron Shows Phase 3 Success: First Oral GLP-1 Drug for Type 2 Diabetes and Weight Loss
2025-04-21
PfizerGLP-1
Pfizer Halts Oral GLP-1 Drug Danuglipron Development Amid Liver Safety Concerns
2025-04-15
LATEST
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
Dividend Exchange Rate for Q3 2025 Announced by DEC on March 12, 2026
2026-03-12
NewHydrogen Files International Patent Application for ThermoLoop Technology to Enhance Hydrogen Production Efficiency
2026-03-12
BioGene Therapeutics Inc. Appoints Raj S. Pruthi as Director
2026-03-12
Arista Networks Introduces Liquid-Cooled XPO Optics for Energy-Efficient Data Centers
2026-03-12
READ MORE
EVENT
2026-03-10
Bioprocessing Summit Europe (Biomanufacturing Trends)
Barcelona, Spain
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
DCAT Week
New York, USA
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
2026-03-23
29th European Biotechnology Congress (Biotech R&D)
Rome, Italy
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea
SEE MORE
Scroll to Top